Mark Beards, Chief Executive Officer
Mark Beards is the CEO of the company. He was formally the Chief Executive Officer at UTILITY therapeutics, which is focused on developing and commercialising antibiotics in the US, to address the significant threat faced by healthcare systems and patients from multi-drug resistant bacterial infections.
Mark has over 28 years’ experience in the life sciences and financial sectors within both global organisations and early stage companies. He has previously held the role of Corporate Development Director, then Group Chief Financial Officer and Executive Board Member, of Celixir plc, a clinical stage biotechnology company focused on developing cellular regenerative therapies.
He brings a detailed understanding of the life sciences industry from his time at Abbott Laboratories (sales & marketing) and GlaxoSmithKline (R&D) This is augmented by his time at McKinsey & Company as a management consultant focused on supporting senior pharmaceutical clients. He has held a number of senior roles in organisations such as Goldman Sachs (Vice President and Head of European Healthcare Equity Research), Charles River Associates (VP, Life Science Strategy), and KPMG (Director, Life Science Strategy)
Mark holds a BA (Hons) and MA in Mathematics from The Queen’s College, Oxford University, and is a fully qualified Chartered Management Accountant